GIUNCHI, VALENTINA
 Distribuzione geografica
Continente #
EU - Europa 294
NA - Nord America 127
AS - Asia 101
AF - Africa 17
OC - Oceania 12
Totale 551
Nazione #
IT - Italia 211
US - Stati Uniti d'America 120
SG - Singapore 52
CN - Cina 34
SE - Svezia 14
CH - Svizzera 13
CI - Costa d'Avorio 11
DE - Germania 11
FI - Finlandia 10
BG - Bulgaria 8
AU - Australia 7
CA - Canada 7
IE - Irlanda 7
IN - India 7
ID - Indonesia 6
NZ - Nuova Zelanda 5
NL - Olanda 4
TG - Togo 4
PT - Portogallo 3
RS - Serbia 3
GB - Regno Unito 2
MA - Marocco 2
PL - Polonia 2
SI - Slovenia 2
ES - Italia 1
FR - Francia 1
JO - Giordania 1
LK - Sri Lanka 1
LT - Lituania 1
RU - Federazione Russa 1
Totale 551
Città #
Bologna 97
Singapore 43
Santa Clara 22
Milan 20
Boardman 12
Abidjan 11
Bern 11
Naples 9
Helsinki 8
New York 8
Sofia 8
Ashburn 7
Dublin 7
Cesena 6
Embrun 6
Jakarta 6
Modena 6
Florence 5
Rome 5
Turin 5
Boydton 4
Lomé 4
Melbourne 4
Mercato Saraceno 4
Auckland 3
Bentivoglio 3
Dallas 3
Jinan 3
Lisbon 3
Mülheim 3
Newcastle 3
Nijmegen 3
Novi Sad 3
Verona 3
Brescia 2
Chandler 2
Chengdu 2
Cinisello Balsamo 2
Dübendorf 2
Gislaved 2
Guangzhou 2
Hamilton 2
Lappeenranta 2
Ljubljana 2
Los Angeles 2
Maenza 2
Mönchengladbach 2
Phoenix 2
Prineville 2
Shanghai 2
Springfield 2
Stuttgart 2
Vaggeryd 2
Warsaw 2
Amman 1
Amsterdam 1
Arezzo 1
Barcelona 1
Beijing 1
Bellante 1
Berkeley Heights 1
Birmingham 1
Buffalo 1
Colombo 1
Council Bluffs 1
Dalmine 1
Hangzhou 1
London 1
Moncalieri 1
Orlando 1
Padova 1
Paris 1
Parma 1
Pune 1
Reggio Emilia 1
San Cesario sul Panaro 1
Seattle 1
Shenzhen 1
Taizhou 1
Tianjin 1
Toronto 1
Washington 1
Wuhan 1
Xi'an 1
Totale 418
Nome #
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System 87
Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System 82
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System 71
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study 62
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People 47
What Is the Safety Profile of Cannabis-Based Medications? Analysis of the Post-Marketing Signals from the FDA Adverse Event Reporting System 44
L’impatto ambientale dei farmaci sulle acque superficiali e la sua stima attraverso i dati di utilizzo 40
The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco-toxicological data to assess and potentially mitigate their diffusion to water supplies 38
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS 38
Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors 33
Post-marketing safety profile of cannabis products: Signals from the FDA adverse event reporting system 27
Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach 13
Totale 582
Categoria #
all - tutte 2.296
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.296


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023129 0 0 0 0 16 8 17 21 17 4 27 19
2023/2024196 10 11 25 34 21 23 1 18 6 14 21 12
2024/2025257 35 54 66 44 33 25 0 0 0 0 0 0
Totale 582